Founded
KANDO id: 348203

Corporate information

Registration country

Company type

Dutch antibody company focused on the use of two proprietary technologies to build a pipeline of innovative human therapeutic antibodies: the Oligoclo

Funding rounds

Profile Country
Bay City Capital LLC

Profile Country
Novartis Services Inc (Novartis Venture Fund)


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials